Consensus Stryker Corporation Mexican S.E.

Stocks

SYK *

US8636671013

Medical Equipment, Supplies & Distribution

End-of-day quote Mexican S.E. 2026-08-19			5-day change	1st Jan Change
5,784.37 ^MXN	-0.48%		-0.48%	-9.62%

08-26	Boston Scientific Says Cyberattack Disrupting Global Operations -- Update	DJ
08-26	Boston Scientific Says Cyberattack Disrupting Global Operations	DJ

Evolution of the Average Target: Stryker Corporation

Evolution of the Target Price: Stryker Corporation

Changes in Analyst Recommendations: Stryker Corporation

7fbd586a3a8698c5fc68d834.lwvIvClnngkVzKfj-akdEWF_e-7RIFibbAsqkdd3zaU.72W51kghq2h5ut6ZppwqUxU5MLmycA22FmRd2uMT_vPDfJ_pGRXfJDiukw~8507ac838d0bac5a74e9f37ca7abea7f

Analysts' recommendations: Stryker Corporation

08-18	Leerink Partners Adjusts Price Target on Stryker to $403 From $407, Maintains Outperform Rating	MT
08-13	Citigroup Adjusts Price Target on Stryker to $399 From $385, Maintains Buy Rating	MT
08-05	Rothschild & Co Redburn Adjusts Stryker Price Target to $360 From $346	MT
08-03	UBS Adjusts Stryker Price Target to $382 From $400, Maintains Buy Rating	MT
08-03	Analyst recommendations: Chevron, Linde, RTX, Colgate-Palmolive, American Electric Power...
07-31	RBC Cuts Price Target on Stryker to $420 From $435, Keeps Outperform Rating	MT
07-31	Evercore ISI Adjusts Stryker Price Target to $355 From $350, Maintains Outperform Rating	MT
07-31	Truist Lifts Price Target on Stryker to $340 From $330, Keeps Hold Rating	MT
07-31	Raymond James Adjusts Price Target on Stryker to $370 From $383, Maintains Outperform Rating	MT
07-31	Jefferies Adjusts Price Target on Stryker to $440 From $455, Maintains Buy Rating	MT
07-31	BTIG Adjusts Price Target on Stryker to $358 From $371, Maintains Buy Rating	MT
07-31	Piper Sandler Adjusts Price Target on Stryker to $390 From $420, Maintains Overweight Rating	MT
07-31	JPMorgan Adjusts Price Target on Stryker to $350 From $400, Maintains Overweight Rating	MT
07-31	Bernstein Adjusts Price Target on Stryker to $420 From $410, Maintains Outperform Rating	MT
07-30	The Fed Gets a Better Inflation Number
07-28	UBS Upgrades Stryker to Buy From Neutral, Adjusts Price Target to $400 From $380	MT
07-14	Goldman Sachs Adjusts Price Target on Stryker to $339 From $363, Maintains Neutral Rating	MT
07-13	BTIG Research Adjusts Stryker Price Target to $371 From $379, Maintains Buy Rating	MT
07-09	Argus Research Adjusts Stryker Price Target to $370 From $350	MT
07-09	BMO Capital Initiates Coverage on Stryker With Outperform Rating, $369 Price Target	MT
07-06	Evercore ISI Adjusts Price Target on Stryker to $350 From $355	MT
06-05	Leerink Partners Adjusts Price Target on Stryker to $407 From $410, Maintains Outperform Rating	MT
05-27	Goldman Sachs Adjusts Price Target on Stryker to $363 From $361, Maintains Neutral Rating	MT
05-13	Rothschild & Redburn Co Adjusts Price Target on Stryker to $346 From $420, Maintains Neutral Rating	MT
05-12	Argus Adjusts Price Target on Stryker to $350 From $435, Maintains Buy Rating	MT

More recommendations

Medical Devices & Implants

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
STRYKER CORPORATION			+16.09%
SMITH & NEPHEW PLC			+19.83%
GLAUKOS CORPORATION			+9.18%
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.			+43.94%
DOUBLE MEDICAL TECHNOLOGY INC.	-	-	+12.82%
INSPIRE MEDICAL SYSTEMS, INC.			-2.27%
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.			+38%
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-	-	-
Average			+19.66%
Weighted average by Cap.			+16.62%